NCT01547156

Brief Summary

Mobile Sipoo is a randomized controlled trial aiming to improve selfcare and outcomes of diabetes and hypertensive patients by introducing a remote patient monitoring system supported with automatic patient decision support. The feedback system is coupled with back-office health coaching.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started May 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

March 2, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 7, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

March 10, 2016

Status Verified

March 1, 2016

Enrollment Period

10 months

First QC Date

March 2, 2012

Last Update Submit

March 9, 2016

Conditions

Keywords

patient decision supporttelemonitoringself-managementremote patient monitoringactive assistance technologyselfcare

Outcome Measures

Primary Outcomes (2)

  • Change in blood pressure

    9 months

  • Change in Hba1c(for diabetes patients)

    9 months

Secondary Outcomes (7)

  • Achieving the desired target range

    9 months

  • Adverse effects

    9 months

  • Hypoglycemia

    9 months

  • Change in body weight

    9 months

  • Change in BMI

    9 months

  • +2 more secondary outcomes

Study Arms (2)

Control group

NO INTERVENTION

Control group received usual care

Telemonitoring group

EXPERIMENTAL

Intervention patients were given a remote patient monitoring toolbox that included a mobile telephone, software application, and assessment devices for measuring and remote reporting of hypertension and diabetes -related health parameters at home. The monitored parameters were body weight, steps, blood pressure and blood glucose. Based on their self-monitored data, patients received feedback that was automatically generated, theory-based, health promotion rich information that aimed at strengthening their self-care practices.

Device: Intervention group

Interventions

Telemonitoring group

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For hypertensive patients: Blood pressure over 140/90 mmHg (systolic and diastolic separately) treated or untreated
  • Diabetes patients: Glycohemoglobin A1c over 6.5% but lower that 11%
  • use of diabetes medication

You may not qualify if:

  • Patients who decline to participate
  • Patients specifically excluded by the health centre physician
  • Patients unable to co-operate, expected poor study compliance (IT illiterate) or reluctance to perform self monitoring
  • Pregnancy
  • Patients with a life expectance of less than one year
  • Patients with major elective surgery planned within 6 months or patient has had major surgery within last 2 months.
  • Patients with psychiatric disorders (depression), abuse of alcohol or narcotics complicating or disabling participation in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sipoo Health Care Centre

Sipoo, Finland

Location

Related Links

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Hypertension

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2012

First Posted

March 7, 2012

Study Start

May 1, 2011

Primary Completion

March 1, 2012

Study Completion

June 1, 2012

Last Updated

March 10, 2016

Record last verified: 2016-03

Locations